NIH Scientists Discover That Proteins Involved in Immunity Potentially Cause Cancer
The findings suggest that these naturally produced mutations are just as powerful as known cancer-causing agents in producing tumors.
Read More
Search Results for: lung cancer
FDA Approves QIAGEN’s therascreen EGFR Test as Companion Diagnostic for Lung Cancer Patients
The test addresses high-volume, high-value need with broad coverage of validated mutations.
Read More
Biodesix Secures Medicare Coverage for VeriStrat Test
The coverage decision means that more than 49 million eligible Medicare enrollees in the United States will now be able to benefit from VeriStrat being a covered diagnostic test, according to specific lung cancer indications outlined by Novitas.
Read More
From the Editor: June 2013: Let’s Get Personal
Robust discussion follows disclosure of an attempt to foil cancer.
Read More
Personalized Medicine: Keeping Up with Change
Reimbursement looms as major challenge
Read More